2016
DOI: 10.1016/j.vaccine.2016.03.025
|View full text |Cite
|
Sign up to set email alerts
|

Sterile inflammation induced by Carbopol elicits robust adaptive immune responses in the absence of pathogen-associated molecular patterns

Abstract: HighlightsCarbopol induces Th1/IgG2a responses without PRR activation.Carbopol polymer morphology is changed by APC phagocytosis leading to ROS induction.This study highlights a potentially novel mechanism for in vivo cellular activation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
24
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 20 publications
(29 citation statements)
references
References 47 publications
5
24
0
Order By: Relevance
“…However, ADJ did not promote stabilized-HIF1α accumulation under normoxia in DCs. It has been also documented that phagolysosomal destabilization after adjuvant phagocytosis, such as Alum and Carbopol, is an important step in inflammasome activation (Gartlan et al, 2016, Hornung et al, 2008. While we have not directly characterized the intracellular location of ADJ in DCs, ADJ increased lysosomal pH, which in turn may result in lysosomal stabilization.…”
Section: How Does Adj Enhance DC Cross-presentation and Potentiate Cdmentioning
confidence: 83%
“…However, ADJ did not promote stabilized-HIF1α accumulation under normoxia in DCs. It has been also documented that phagolysosomal destabilization after adjuvant phagocytosis, such as Alum and Carbopol, is an important step in inflammasome activation (Gartlan et al, 2016, Hornung et al, 2008. While we have not directly characterized the intracellular location of ADJ in DCs, ADJ increased lysosomal pH, which in turn may result in lysosomal stabilization.…”
Section: How Does Adj Enhance DC Cross-presentation and Potentiate Cdmentioning
confidence: 83%
“…APCs [e.g., murine immature (day 6) bone marrow-derived DCs (BMDCs) or bone marrow-derived macrophages (BMDMs) prepared as in Current Protocols articles (Inaba et al, 2009;Harding, 2001)] Complete RPMI-10 medium (see recipe), 37°C Fluorescently labeled phagocytic target [e.g., zymosan A-Alexa Fluor 488 (Molecular Probes, #Z23373), CFSE-labeled apoptotic cells (Baxter et al, 2014), or Carbopol-Alexa Fluor 488 (Gartlan et al, 2016)] 5 mM EDTA in phosphate-buffered saline (PBS; containing Ca 2+ and Mg 2+ ), 37°C FACS buffer (see recipe), 4°C Surface-staining monoclonal antibody (mAb; e.g., MHC class II-Alexa Fluor 647, BioLegend, #107618, RRID: AB_493525 or CD11c-Alexa Fluor 647, BioLegend, #117312, RRID: AB_389328) 0.5 µg/ml Hoechst 33342…”
Section: Methodsmentioning
confidence: 99%
“…Optional: Prepare additional duplicate wells containing sterile 13-mm glass coverslips to enable parallel in situ confocal microscopy or scanning electron microscopy studies to be performed (Gartlan et al, 2016). 2. Incubate plate for 1 hr in a 37°C, 5% CO 2 tissue culture incubator to allow the cells to adhere/stabilize.…”
Section: Phagocytosis Assaymentioning
confidence: 99%
See 2 more Smart Citations